Skip to main content
Erschienen in: Annals of Surgical Oncology 8/2016

30.03.2016 | Breast Oncology

Genetic Determinants of Nipple Aspiration Fluid Yield

verfasst von: Ali Shidfar, MD, Jun Wang, PhD, Elliot Wiesenfeld, BS, Wei Zhang, PhD, Denise Scholtens, PhD, Angela Fought, MS, Robert T. Chatterton, PhD, Seema A. Khan, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Nipple aspiration fluid (NAF) is a non-invasively-acquired biosample that can provide a window into the breast environment, but NAF yield is highly variable. Its determinants must be better understood for studies of breast cancer risk. The wet earwax phenotype was identified as one determinant of NAF yield in the 1970s, and is linked to single nucleotide polymorphisms (SNPs) in the ATP-binding cassette transporter gene ABCC11. We have investigated this, as well as SNPs in the prolactin (PRL) and prolactin receptor (PRLR) genes, in relation to NAF yield.

Methods

DNA was extracted from white blood cells of 557 NAF yielders and 359 non-yielders, and was used to genotype ABCC11 (rs17822931), PRL (rs849870, rs849872, rs849886, rs2244502, rs1341239), and PRLR (rs37364, rs34024951, rs1610218, rs9292575, rs7718468) using Taqman genotyping assay. The association between NAF yield and each single SNP was analyzed using logistic regression adjusting for age, race, and menopausal status.

Results

ABCC11 rs17822931 showed a negative association with NAF yield [odds ratio (OR) 0.66, 95 % confidence interval (CI) 0.49–0.88; p = 0.004]. The PRL rs849870 and the haplotype combination with other SNPs showed a marginal association with NAF yield. In addition, the years since last birth also showed negative association with NAF yielding (OR 0.98, 95 % CI 0.96–0.99; p = 0.001). The combination of the years since last birth with ABCC11 SNP revealed significant interaction between reproductive factor and genetic factor.

Conclusions

Our results confirmed the association between NAF yield and earwax phenotype through ABCC11 genotype. Combined with the recency of last birth, ABCC11 genotype should be considered in the design of studies utilizing NAF as a biosample.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Reid SE, Murthy MS, Kaufman M, Scanlon EF. Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer. Br J Surg. 1996;83:1037–46.CrossRefPubMed Reid SE, Murthy MS, Kaufman M, Scanlon EF. Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer. Br J Surg. 1996;83:1037–46.CrossRefPubMed
2.
Zurück zum Zitat Khan SA, Chatterton RT Jr. Cellular and hormonal content of breast nipple aspirate fluid in relation to the risk of breast cancer. Biomark Med. 2008;2:479–93.CrossRefPubMed Khan SA, Chatterton RT Jr. Cellular and hormonal content of breast nipple aspirate fluid in relation to the risk of breast cancer. Biomark Med. 2008;2:479–93.CrossRefPubMed
3.
Zurück zum Zitat Alexander H, Stegner AL, Wagner-Mann C, et al. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res. 2004;10:7500–10.CrossRefPubMed Alexander H, Stegner AL, Wagner-Mann C, et al. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res. 2004;10:7500–10.CrossRefPubMed
4.
Zurück zum Zitat Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst. 2001;93:1791–98.CrossRefPubMed Wrensch MR, Petrakis NL, Miike R, et al. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. J Natl Cancer Inst. 2001;93:1791–98.CrossRefPubMed
5.
Zurück zum Zitat Petrakis NL. ASPO distinguished achievement award lecture. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev. 1993;2:3–10. Petrakis NL. ASPO distinguished achievement award lecture. Studies on the epidemiology and natural history of benign breast disease and breast cancer using nipple aspirate fluid. Cancer Epidemiol Biomarkers Prev. 1993;2:3–10.
6.
Zurück zum Zitat Sauter ER, Ross E, Daly M, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer. 1997;76:494–501.CrossRefPubMedPubMedCentral Sauter ER, Ross E, Daly M, et al. Nipple aspirate fluid: a promising non-invasive method to identify cellular markers of breast cancer risk. Br J Cancer. 1997;76:494–501.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Petrakis NL, Mason L, Lee R, et al. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration. J Natl Cancer Inst. 1975;54:829–34.PubMed Petrakis NL, Mason L, Lee R, et al. Association of race, age, menopausal status, and cerumen type with breast fluid secretion in nonlactating women, as determined by nepple aspiration. J Natl Cancer Inst. 1975;54:829–34.PubMed
8.
Zurück zum Zitat Wrensch MR, Petrakis NL, Gruenke LD, et al. Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat. 1990;15:39–51.CrossRefPubMed Wrensch MR, Petrakis NL, Gruenke LD, et al. Factors associated with obtaining nipple aspirate fluid: analysis of 1428 women and literature review. Breast Cancer Res Treat. 1990;15:39–51.CrossRefPubMed
9.
Zurück zum Zitat Fought AJ, McGathey C, Scholtens DM, et al. Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls. Cancer Epidemiol Biomark Prev. 2013;22:2277–84.CrossRef Fought AJ, McGathey C, Scholtens DM, et al. Hormonal determinants of nipple aspirate fluid yield among breast cancer cases and screening controls. Cancer Epidemiol Biomark Prev. 2013;22:2277–84.CrossRef
10.
Zurück zum Zitat Yoshiura K, Kinoshita A, Ishida T, et al. A SNP in the ABCC11 gene is the determinant of human earwax type. Nat Genet. 2006;38:324–30.CrossRefPubMed Yoshiura K, Kinoshita A, Ishida T, et al. A SNP in the ABCC11 gene is the determinant of human earwax type. Nat Genet. 2006;38:324–30.CrossRefPubMed
11.
Zurück zum Zitat Lee SA, Haiman CA, Burtt NP, et al. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. BMC Med Genet. 2007;8:72.CrossRefPubMedPubMedCentral Lee SA, Haiman CA, Burtt NP, et al. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort. BMC Med Genet. 2007;8:72.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Mong FY, Kuo YL, Liu CW, et al. Association of gene polymorphisms in prolactin and its receptor with breast cancer risk in Taiwanese women. Mol Biol Rep. 2011;38:4629–36.CrossRefPubMed Mong FY, Kuo YL, Liu CW, et al. Association of gene polymorphisms in prolactin and its receptor with breast cancer risk in Taiwanese women. Mol Biol Rep. 2011;38:4629–36.CrossRefPubMed
13.
Zurück zum Zitat Nyante SJ, Faupel-Badger JM, Sherman ME, et al. Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland. Breast Cancer Res. 2011;13:R42.CrossRefPubMedPubMedCentral Nyante SJ, Faupel-Badger JM, Sherman ME, et al. Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland. Breast Cancer Res. 2011;13:R42.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Vaclavicek A, Hemminki K, Bartram CR, et al. Association of prolactin and its receptor gene regions with familial breast cancer. J Clin Endocrinol Metab. 2006;91:1513–19.CrossRefPubMed Vaclavicek A, Hemminki K, Bartram CR, et al. Association of prolactin and its receptor gene regions with familial breast cancer. J Clin Endocrinol Metab. 2006;91:1513–19.CrossRefPubMed
15.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837–45.CrossRefPubMed
16.
17.
Zurück zum Zitat Petrakis NL, Ernster VL, Sacks ST, et al. Epidemiology of breast fluid secretion: association with breast cancer risk factors and cerumen type. J Natl Cancer Inst. 1981;67:277–84.PubMed Petrakis NL, Ernster VL, Sacks ST, et al. Epidemiology of breast fluid secretion: association with breast cancer risk factors and cerumen type. J Natl Cancer Inst. 1981;67:277–84.PubMed
18.
Zurück zum Zitat Bortfeld M, Rius M, Konig J, et al. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience. 2006;137:1247–57.CrossRefPubMed Bortfeld M, Rius M, Konig J, et al. Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience. 2006;137:1247–57.CrossRefPubMed
19.
Zurück zum Zitat Chen ZS, Guo Y, Belinsky MG, et al. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol. 2005;67:545–57.CrossRefPubMed Chen ZS, Guo Y, Belinsky MG, et al. Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol. 2005;67:545–57.CrossRefPubMed
20.
Zurück zum Zitat Guo Y, Kotova E, Chen ZS, et al. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine. J Biol Chem. 2003;278:29509–14.CrossRefPubMed Guo Y, Kotova E, Chen ZS, et al. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′-dideoxycytidine and 9′-(2′-phosphonylmethoxyethyl)adenine. J Biol Chem. 2003;278:29509–14.CrossRefPubMed
21.
Zurück zum Zitat Ota I, Sakurai A, Toyoda Y, et al. Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11. Anticancer Res. 2010;30:5189–94.PubMed Ota I, Sakurai A, Toyoda Y, et al. Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11. Anticancer Res. 2010;30:5189–94.PubMed
22.
Zurück zum Zitat Beesley J, Johnatty SE, Chen X, et al. No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women. Breast Cancer Res Treat. 2011;126:235–39.CrossRefPubMed Beesley J, Johnatty SE, Chen X, et al. No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women. Breast Cancer Res Treat. 2011;126:235–39.CrossRefPubMed
23.
Zurück zum Zitat Tikk K, Sookthai D, Johnson T, et al. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. Ann Oncol. 2014;25:1422–28.CrossRefPubMed Tikk K, Sookthai D, Johnson T, et al. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort. Ann Oncol. 2014;25:1422–28.CrossRefPubMed
24.
Zurück zum Zitat Suijkerbuijk KP, van der Wall E, Meijrink H, et al. Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer. Fam Cancer. 2010;9:321–25.CrossRefPubMedPubMedCentral Suijkerbuijk KP, van der Wall E, Meijrink H, et al. Successful oxytocin-assisted nipple aspiration in women at increased risk for breast cancer. Fam Cancer. 2010;9:321–25.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Zhang L, Shao ZM, Beatty P, et al. The use of oxytocin in nipple fluid aspiration. Breast J. 2003;9:266–68.CrossRefPubMed Zhang L, Shao ZM, Beatty P, et al. The use of oxytocin in nipple fluid aspiration. Breast J. 2003;9:266–68.CrossRefPubMed
26.
Zurück zum Zitat Huang Y, Anderson KE, Nagamani M, et al. Dietary intake of lactose as a strong predictor for secretor status of nipple aspirate fluid in healthy premenopausal nonlactating women. Clin Cancer Res. 2008;14:1386–92.CrossRefPubMedPubMedCentral Huang Y, Anderson KE, Nagamani M, et al. Dietary intake of lactose as a strong predictor for secretor status of nipple aspirate fluid in healthy premenopausal nonlactating women. Clin Cancer Res. 2008;14:1386–92.CrossRefPubMedPubMedCentral
Metadaten
Titel
Genetic Determinants of Nipple Aspiration Fluid Yield
verfasst von
Ali Shidfar, MD
Jun Wang, PhD
Elliot Wiesenfeld, BS
Wei Zhang, PhD
Denise Scholtens, PhD
Angela Fought, MS
Robert T. Chatterton, PhD
Seema A. Khan, MD
Publikationsdatum
30.03.2016
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 8/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5163-x

Weitere Artikel der Ausgabe 8/2016

Annals of Surgical Oncology 8/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.